Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer: a Cochrane Review

Niranjan J. Sathianathen, Yiannis A. Philippou, Gretchen M. Kuntz, Badrinath R. Konety, Shilpa Gupta, Alastair D. Lamb, Philipp Dahm

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations

Abstract

To provide a precis of the Cochrane Collaboration Review of taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer by Sathianathen NJ, Philippou YA, Kuntz GM et al. Cochrane Database of Systematic Reviews 2018, Issue 10. Art. No.: CD012816. https://doi.org/10.1002/14651858.cd012816.pub2.

Original languageEnglish (US)
Pages (from-to)370-372
Number of pages3
JournalBJU International
Volume124
Issue number3
DOIs
StatePublished - Sep 2019

Bibliographical note

Publisher Copyright:
© 2019 The Authors BJU International © 2019 BJU International Published by John Wiley & Sons Ltd

Keywords

  • #PCSM
  • #ProstateCancer
  • chemotherapy
  • meta-analysis
  • systematic review

Fingerprint

Dive into the research topics of 'Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer: a Cochrane Review'. Together they form a unique fingerprint.

Cite this